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Abstract
Background—There have been reports that by compensating for the ocular aberrations using
adaptive optical systems it may be possible to improve the resolution of clinical retinal imaging
systems beyond what is now possible. In order to develop such system to observe eyes with retinal
disease, understanding of the ocular wavefront aberrations in individuals with retinal disease is
required.
Methods—82 eyes of 66 patients with macular disease (epiretinal membrane, macular edema,
macular hole etc.) and 85 eyes of 51 patients without retinal disease were studied. Using a ray-
tracing wavefront device, each eye was scanned at both small and large pupil apertures and
Zernike coefficients up to 6th order were acquired.
Results—In phakic eyes, 3rd order root mean square errors (RMS) in macular disease group were
statistically greater than control, an average of 12% for 5mm and 31% for 3mm scan diameters
(p<0.021). In pseudophakic eyes, there also was an elevation of 3rd order RMS, on average 57%
for 5mm and 51% for 3mm scan diameters (p<0.031).
Conclusion—Higher order wavefront aberrations in eyes with macular disease were greater than
in control eyes without disease. Our study suggests that such aberrations may result from irregular
or multiple reflecting retinal surfaces. Modifications in wavefront sensor technology will be
needed to accurately determine wavefront aberration and allow correction using adaptive optics in
eyes with macular irregularities.
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Introduction
Retinal imaging is an important objective method to assess retinal structure and integrity,
study retinal disease, visualize the ocular circulation and monitor the effect of treatment on
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Brief Summary The ocular wavefront contains more aberrations in eyes with macular disease. Such wavefront aberrations will limit
the use of adaptive optical compensation unless they can be corrected for in imaging systems designed to use adaptive optics to
improve the imaging of the macula.
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retinal disease. The resolution of retinal photographic equipment is limited by the optical
power of the last imaging lens - the human eye. The many imperfections in the human eye
include chromatic aberrations, coma, spherical aberrations, astigmatism, and higher order
aberrations. Thus, the transverse resolution in retinal photography is in the order of 15 to 20
microns while the axial or longitudinal resolution in confocal SLO of the eye is in the order
of 300 to 450 microns.1
There are several areas of ophthalmology where high-resolution imaging will offer
significant benefits. These areas include ocular melanoma, tumor vessel characterization,2
age-related macular degeneration, choroidal neovascularization, diabetic retinopathy, AIDS,
glaucoma, study of macular vitreoretinal interface disorders and retinal thickness
measurement. Development of high-resolution fundus imaging will improve our
understanding and possibly treatment of many retinal disorders.
Several groups have suggested that by compensating for ocular aberrations using adaptive
optical systems3–8 it may be possible to improve the resolution of clinical retinal imaging
systems. One potential advantage of compensating for ocular aberrations is the ability to
directly observe the photoreceptors and microscopic pathologic structures. In healthy human
eyes, there have been reports that this may be possible in optimal conditions.3,5–7 The
ability to image the photoreceptors, RPE cells and other structures would have important
research and clinical implications relating to disease detection and treatment and
understanding pathophysiology. For these reasons, it is important to understand the ocular
aberrations present in human eyes with retinal disease. One group of diseases for which
improved imaging might be very important is macular diseases. We therefore undertook a
study of patients with a variety of macular pathologies. Understanding the range of and
types of wavefront aberrations present is an important step in developing devices to
compensate for these aberrations and allow improved imaging of normal and pathological
eyes.
Subjects and Methods
Patient Characteristics
The study population consisted of 80 eyes of 66 patients with retinal disease (36 male, 30
female), of these 37 eyes were phakic and 43 were pseudophakic. For controls, 78 eyes of 49
patients without retinal disease (18 male, 31 female) were imaged, of these 44 eyes were
phakic and 34 were pseudophakic. There was no statistical difference between disease and
control group in age and conventional refraction except for cylinder in pseudophakic study
[Table 1].
Table 2 lists the retinal diseases that were present. In all cases, patients had clinically
diagnosed macular disease that caused irregularity of the retinal surface. Choroidal
neovascularization (CNV) included subretinal hemorrhage and pigment epithelium
detachment, with or without exudative retinal detachment, and macular edema (ME) induced
by pseudophakia, retinal vein occlusion, diabetic retinopathy or uveitis. Diseases with
associated vitreous opacity were excluded, as well as optically significant cataract, apparent
dislocation of the intraocular lens or any eye surgery within six months prior to
measurement.
Methods
In all cases, ocular wavefront aberrations were measured using the Tracey Visual Function
Analyzer (VFA software version 1.0, Tracey Technologies, Houston, TX), which is based
on ray-tracing principle.9–14
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The device projects 64 light rays located in 4 concentric circles across the pupil in
succession and detects the retinal location of reflection within 0.06 seconds with the help of
two linear charged coupled device (CCD) arrays. Based on these measurements the device
calculates the retinal point spread function (PSF) and subsequently the wavefront
aberrations. Conventional refractive indexes are also generated by reverse calculation of
Zernike coefficients and therefore depend on the analysis area size. A single measurement
constitutes a complete examination for each eye. In a recent unpublished study we measured
the reproducibility of the VFA and found that the Root Mean Square (RMS) of Zernike
terms had a ratio of standard deviation to mean measurement value of 57%. The results were
similar to the findings by other researchers when comparing the reading of conventional
refraction.9,13–15
The VFA has an automatic acquisition mode that measures wavefront at maximum available
pupil size as a default setting, as well as a manual mode in which area size is adjustable.
Each eye was scanned at maximum pupil size in early part of the study, and subsequently
pupil size was fixed to 3mm and 6mm diameters for phakic and 5mm diameters for
pseudophakic eyes. Each patient eye was dilated using 2–3 sets of 1% tropicamide and 2.5%
phenylephrine eye drops before measurement, and for both scan sizes wavefront was
measured two to four times by one examiner [KB]. From the data one best scan was selected
for each scan size respectively by one reviewer [KB]. In cases where the clear optical zone
of the intraocular lens implant was small, or the pupil was small, the scanning area was
restricted and therefore less number of the eye was available for the large scan area study.
Data of 25 Zernike coefficients (2nd to 6th order) were downloaded onto computer software
(Microsoft Excel v.X, Microsoft, Redmond, WA) for both small and large scans. From 3mm
scan data conventional refraction data (Sph, Cyl, Ax) were also downloaded.
Several reports have described that wavefront values depend on the size of analysis area.16–
19 To compare the data scanned at different pupil size, it has been suggested to
mathematically transforming the data into a unified pupil size.16,17 The equation described
by Schwiegerling17 is as follows (modified by author [KB] for use of coefficients up to 6th
order);
where anm is an original Zernike coefficient, bnm is a new coefficient, r1 is an original radius
of analysis area, r2 is a new radius to be transformed. Coefficients are described in double
index scheme; n and m indicate radial order and spatial frequency, respectively. This
equation cannot predict the wavefront of larger analysis area, thus the new, unified analysis
area is limited to be smaller than the original area.
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Using this equation all large scan size measurement data were transformed to that of 5mm
diameter. For small scan size measurement, since it was designed to perform at constant
3mm scan size, non-transformed data were used.
The root mean square (RMS) errors for each Zernike term were calculated, as well as
several combined indexes shown in Tables 3 and 4.
S2 to S6 indicate the root mean square value (RMS) of the 2nd (C3 to C5), through 6th (C21
to C27) order Zernike coefficients individually. The total HO is the RMS of higher order
terms (C6 to C27); the total RMS is the RMS of all 25 Zernike terms.
Statistical analysis was performed using another computer software (JMP IN ver. 4.0.2, SAS
institute inc. Cary, NC).
Effect of eccentric fixation on wavefront error
In order to test the hypothesis that eccentric fixation at the juxtamacular area that might
occur in patients with macular disease would cause an increase in wavefront abnormalities,
we tested four normal healthy individuals without macular pathology. In each case, the
subject was asked to fixate on the internal fixation target of the instrument, simultaneously
co-locating another target (A) at a 1m distance using the fellow eye. The distant target (A)
was placed so that subjectively it was overlapped on the internal target image. Wavefront
measurements were done using fellow eye fixation. Eccentric fixation testing was done
using fellow eye fixation and a target (B), 8.7cm apart from the initial target (A) for 5-
degrees of eccentricity, another target (C) that was 17.6cm apart was used for 10-degrees of
eccentricity. Data was acquired using the same protocol as above. A comparison of the
Zernike polynomials was made in the three positions.
Results
Phakic Eye Study
In eyes with macular disease, total RMS (RMS of 25 Zernike coefficients) ranged from
0.144 to 7.377μm (2.545±1.625 (5mm scan), 1.044±0.729 (3mm scan), Mean±SD), total
higher order RMS (Total HO: RMS of C6 to C27) ranged from 0.054 to 1.858μm
(0.422±0.281 (5mm scan), 0.140±0.081 (3mm scan)). Table 3 shows the difference of RMS
error between phakic patients with normal maculae and those with macular disease. Eyes
with macular disease had greater wavefront aberrations than normal in most wavefront
indexes. The wavefront differences ranged from −0.4% to 62% of the values in the normals,
and differences were statistically significant for 3rd order and total higher order RMS for
both scan sizes. For the other RMS values the trend almost consistently indicated that
macular irregularities were associated with higher wavefront abnormalities.
Pseudophakic eye study
Table 4 shows the difference in RMS error between patients who had an IOL implant with a
normal macula and those with macular disease. Total RMS ranged from 0.167 to 3.910μm
(2.158±0.785 (5mm scan), 0.745±0.401 (3mm scan), Mean±SD), and total higher order
RMS (Total HO) ranged from 0.037 to 1.942μm (0.656±0.368 (5mm scan), 0.223±0.182
(3mm scan)). Eyes with macular disease had greater wavefront aberrations than eyes with
normal maculae in most wavefront indexes. The wavefront differences ranged from 12% to
93% of the values in the normals, and these differences were statistically significant for 2nd
and 3rd, total higher order RMS and total RMS for both scan diameters. For the other RMS
values the trend consistently indicated that macular irregularities were associated with
higher wavefront abnormalities.
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For both phakic and pseudophakic studies with both scan sizes the 3rd order RMS value was
always statistically higher in the eyes with macular disease (S3, P<0.021). Table 5 shows the
detailed profile of the 3rd order indexes that comprise S3. All indexes were greater in the
macular disease group than controls, however, difference was not significant.
Effect of eccentric fixation on wavefront error
The total RMS value of the centric, 5- and 10-degree eccentric fixation control subjects was
0.492±0.315, 0.516±0.248 and 0.604±0.247 (p=0.625 for 0 deg vs. 5deg, 0.375 for 0 deg vs.
10 deg. Paired Wilcoxon rank-sum test). Similarly there was no difference between the
groups in individual RMS Zernike terms (Table 6).
In addition, in analyzing the main study data, we reviewed the stored photographs of the
pupil and the corneal reflex of four reference markers to determine whether patients with
and without macular disease did fixate centrally at the moment of data acquisition. In all
cases, we were not able to document fixation failure.
Discussion
In order to use adaptive optics to improve the ability to image the retina, it is necessary to
obtain data on the wavefront aberrations of each subject's eye and to compensate for these
aberrations.3,4,6–8 All currently available wavefront sensing systems are double-pass
systems that assume an essentially flat, regular posterior pole of the eye. In order to
determine the wavefront of an individual eye, these systems rely on one of several
techniques to measure the wavefront.
The Tscherning aberroscope projects a grid of points onto the retina, the distortion of the
grid of points is photographed and from this, wavefront aberrations are calculated.20 The
Hartmann-Shack wavefront sensor technique relies on the projection of a point source light
on the retina. The light reflected from this point on the retina is imaged onto a lenslet array
and sampled with a CCD chip. Wavefront aberrations are calculated assuming that a point of
light on the retina was the origin of the image.11 The Skiaskopy technique effectively
performs retinoscopy at multiple points over the pupil and from these data, multiple
refractive errors the wavefront over the entire exit pupil is calculated.12 The laser ray-
tracing technique, which we employed in this study uses projection of a thin infrared laser
beam onto the retina and detects the location of reflection one by one in succession. This is
sequentially completed over 64 sampling points within 0.06 seconds so that the eye
movement does not effect the measurement. The merit of this technique is that it can detect
larger magnitude errors of reflection than Hartmann-Shack methods, and that it is more
rapid and sensitive than the Tscherning methods that essentially require averaging of data
from each sampling point.
We studied pseudophakic and phakic patients separately because pseudophakic eyes have
different internal optics and there have been reports suggesting that pseudophakic eyes have
different wavefront values.21–23 Indeed there was a difference in wavefront results between
pseudophakic and phakic patients for both small and large pupil diameters. In general,
pseudophakic eyes had higher wavefront errors (S3–S6) with the exception of astigmatism
(Z3+Z5 or S2-defocus) and defocus (Z4) that are probably minimized in pseudophakic eyes
by cataract surgery and the associated intraocular lens implant (Table 7). This was consistent
with clinical studies suggesting more higher-order aberrations in pseudophakic eyes,
although it should be considered that the pseudophakic group in our study was made up of a
significantly older population than the phakic group (See Table 1).
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In our study we noted that for both small and large pupils, in both pseudophakic and phakic
eyes, the wavefront error in eyes with macular disease was larger for all parameters than that
in eyes without macular disease. In approximately one third of the studied values this was
statistically significant, and in the remainder there was a trend in this direction. One possible
explanation might be that eyes with macular disease fixated eccentrically.24 We ruled this
out by studying eccentric fixation in a group of normal subjects and found that paramacular
fixation did not affect the wavefront values. In addition, all measurements were performed
by one examiner checking patient's fixation, and moreover, in review of the pupil images
taken at the time of measurements, we found no obvious eccentric fixation in our cohort.
Another explanation is that the micro-displacement of the intraocular optics especially in
pseudophakic eyes. It may be possible that focal intraocular proliferation in eyes with retinal
disease results in tilt or decentration of the lens implant. However, the elevation of the 3rd
order RMS was observed throughout pseudophakic and phakic study.
We conclude that irregular focal elevation or depression of the retina in or near the posterior
pole of the eye will cause wavefront abnormalities because many wavefront sensing devices
designed for use in the human eye assume a smooth reflecting surface that is not present in
eyes with macular disease and retinal surface irregularities. Histopathology of eyes with
CNV for example shows the irregularities of the retinal surface yielding peak elevations
spaced at intervals between 30 and 360 microns.25,26 Figure 1 shows how an irregular
retinal surface would adversely effect on wavefront aberrations in either device with a small
retinal sampling area (around 100 microns diameter in devices such as a Hartmann-Shack
wavefront sensor) or wavefront sensors that require a large retinal sampling area
(Tscherning aberroscopy, laser ray tracing or skiascopy). In both cases eyes with irregular
retinal surface profiles with or without multiple retinal and subretinal optical interfaces blur
the wavefront image and have a degrading effect on light reflection for all wavefront
sensors. In this study we only evaluated one of the four types of wavefront sensors currently
available. Future studies in patients with macular diseases will allow us to determine which
technique is less affected by macular irregularities.
For these reasons, new techniques will have to be developed to allow accurate wavefront
measurements without this assumption. This is important because the ability to apply
adaptive optics to retinal imaging will be particularly important in eyes with macular
disease. It is possible that certain existing techniques will be less effected by macular
irregularities. Of the four techniques in clinical use, Tscherning aberroscopy, skiascopy and
ray tracing devices utilize a larger retinal image area to generate wavefront measurements.
In contrast, the Hartmann-Shack techniques may use a smaller area on the order of 50–100
microns that may be particularly susceptible to distortions of macular topography at a given
measurement. However, our study only analyzed the effect of macular irregularities on one
of these instruments. The effect of macular irregularities on the three other instruments
(skiascopy, Tscherning aberroscopy and Hartmann-Shack wavefront sensing) needs to be
investigated. At the current time, retinal cameras are not incorporated into these instruments
but such a camera could aid the operator to find a flat imaging area.
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Figure 1.
Diagram of the light reflection at normal and irregular retinal surfaces for small and large
retinal measurement area. Figure 1A shows the possible light reflection in a normal eye with
a wavefront sensor that uses a small retinal area for light reflection. Figure 1B shows the
possible explanation of light reflection in a diseased eye with the same type of wavefront
sensors. Figure 1C shows the possible light reflection in a normal eye with a wavefront
sensor that uses a large retinal area for light reflection, while Figure 1D shows the possible
explanation of light reflection in a diseased eye.
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Table 1
Number, age and conventional refraction of eyes studied
Phakic Macular Disease Control P*
Eyes/Patients 36/32 44/28
Age 65.7±11.1yo 63.8±14.0yo 0.493
Sph 0.2±3.0D 0.1±2.7D 0.801
Cyl −1.4±0.8D −1.3±0.8D 0.559
Spherical Equivalent −0.4±3.2D −0.6±2.7D 0.877
Pseudophakic Macular Disease Control P*
Eyes/Patients 44/34 33/21
Age 74.5±12.3yo 75.7±8.3yo 0.644
Sph 0.2±1.8D 0.6±0.8D 0.233
Cyl −1.8±1.1D −1.0±0.7D 0.001
Spherical Equivalent −0.7±1.8D 0.1±0.9D 0.019
Mean±SD
*ANOVA
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Table 2
Number and type of macular lesions studied (3mm)
Disease Lens Status N
Macular Edema Phakic 13
Pseudophakic 11
Choroidal Neovascularization Phakic 4
Pseudophakic 8
Epiretinal Membrane Phakic 10
Pseudophakic 6
Geographic Atrophy Phakic 1
Pseudophakic 8
Macular Hole Phakic 2
Pseudophakic 5
Macular Scar Phakic 6
Pseudophakic 6
Total 80
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Table 3
Comparison of wavefront in phakic eyes
Scan: 5mm Disease Total Control 1 %Difference* P†
S2 2.466±1.668 2.476±2.109 −0.4% 0.492
S2 -defocus 0.823±0.572 0.770±0.484 6.8% 0.882
S3 0.175±0.074 0.156±0.097 12.3% 0.021
S4 0.059±0.067 0.037±0.029 61.9% 0.071
S5 0.034±0.049 0.026±0.024 29.1% 0.015
S6 0.373±0.280 0.279±0.161 33.9% 0.607
Total HO 0.422±0.281 0.328±0.176 28.8% 0.019
Total RMS 2.545±1.625 2.506±2.106 1.6% 0.350
Scan: 3mm Disease Total Control 1 %Difference* P†
S2 1.03±0.73 0.854±0.503 20.7% 0.332
S2 -defocus 0.337±0.17 0.291±0.172 15.9% 0.201
S3 0.123±0.073 0.094±0.053 31.1% 0.009
S4 0.052±0.042 0.047±0.033 11.0% 0.364
S5 0.019±0.017 0.016±0.012 19.9% 0.616
S6 0.013±0.012 0.013±0.012 6.0% 0.654
Total HO 0.14±0.081 0.11±0.059 27.0% 0.017
Total RMS 1.044±0.729 0.863±0.502 20.9% 0.289
Mean±SD
S2: RMS of C3 to C5 (2nd order indexes), S2-Defocus: RMS of C3 and C5, S3: RMS of C6 to C9 (3rd order indexes), S4: RMS of C10 to C14
(4th order indexes), S5: RMS of C15 to C20 (5th order indexes), S6: RMS of C21 to C27 (6th order indexes), Total HO: RMS of S3 to S6, Total
RMS: RMS of S2 to S6
*%(Disease-Control1)/control1
†ANOVA on logarithm of each value
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Table 4
Comparison of wavefront in pseudophakic eyes
Scan: 5mm Disease Total Control 2 %Difference* P†
S2 2.021±0.792 1.046±0.355 93.2% 0.001
S2 -defocus 1.216±0.685 0.749±0.312 62.3% 0.016
S3 0.517±0.321 0.329±0.155 57.4% 0.009
S4 0.289±0.193 0.257±0.073 12.4% 0.923
S5 0.162±0.180 0.105±0.091 53.9% 0.210
S6 0.096±0.097 0.070±0.048 36.1% 0.477
Total HO 0.656±0.368 0.460±0.132 42.8% 0.024
Total RMS 2.158±0.785 1.156±0.335 86.7% 0.001
Scan: 3mm Disease Total Control 2 %Difference* P†
S2 0.677±0.419 0.368±0.185 84.1% 0.001
S2 -defocus 0.423±0.282 0.244±0.172 73.8% 0.006
S3 0.176±0.155 0.117±0.067 51.0% 0.031
S4 0.108±0.102 0.068±0.047 58.7% 0.051
S5 0.042±0.042 0.025±0.016 66.5% 0.213
S6 0.032±0.033 0.02±0.013 60.0% 0.564
Total HO 0.223±0.182 0.144±0.075 54.5% 0.026
Total RMS 0.745±0.401 0.401±0.186 85.7% 0.000
*%(Disease-Control2)/control2
†ANOVA on logarithm of each value
Retina. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Bessho et al. Page 14
Ta
bl
e 
5
Pr
of
ile
s o
f 3
rd
 
o
rd
er
 R
M
S
Ph
ak
ic
Sc
an
: 3
m
m
Sc
an
: 5
m
m
D
ise
as
e
C
on
tr
ol
P*
D
ise
as
e
C
on
tr
ol
P*
Z6
0.
05
7±
0.
04
0
0.
04
±0
.0
36
0.
05
4
0.
26
3±
0.
37
2
0.
13
5±
0.
13
8
0.
08
2
Z7
0.
05
5±
0.
04
6
0.
05
3±
0.
04
3
0.
91
9
0.
28
8±
0.
43
0
0.
22
4±
0.
25
1
0.
24
3
Z8
0.
04
3±
0.
04
8
0.
03
±0
.0
25
0.
29
5
0.
19
5±
0.
19
7
0.
13
3±
0.
12
5
0.
32
2
Z9
0.
05
5±
0.
06
3
0.
04
1±
0.
03
0.
46
0
0.
18
1±
0.
17
6
0.
13
6±
0.
14
3
0.
34
4
Ps
eu
do
-p
ha
ki
c
Sc
an
: 3
m
m
Sc
an
: 5
m
m
D
ise
as
e
C
on
tr
ol
P*
D
ise
as
e
C
on
tr
ol
P*
Z6
0.
06
6±
0.
07
4
0.
05
1±
0.
03
9
0.
80
4
0.
24
6±
0.
31
9
0.
16
0±
0.
12
7
0.
62
9
Z7
0.
08
0±
0.
12
0
0.
06
6±
0.
05
3
0.
71
8
0.
30
1±
0.
24
8
0.
19
4±
0.
17
3
0.
33
8
Z8
0.
08
1±
0.
10
1
0.
04
5±
0.
04
5
0.
02
8
0.
23
6±
0.
21
0
0.
11
2±
0.
07
5
0.
25
7
Z9
0.
06
6±
0.
05
7
0.
04
0±
0.
03
7
0.
06
7
0.
14
7±
0.
10
7
0.
09
7±
0.
07
4
0.
48
7
*
A
N
O
V
A
 o
n 
lo
ga
rit
hm
 o
f e
ac
h 
va
lu
e
Retina. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Bessho et al. Page 15
Ta
bl
e 
6
Th
e 
ef
fe
ct
 o
f e
cc
en
tri
c 
fix
at
io
n 
on
 w
av
ef
ro
nt
 m
ea
su
re
m
en
t
C
en
te
re
d
5 
de
g
10
 d
eg
P*
 
v
s.
 5
de
g
P*
 
v
s.
 1
0d
eg
S2
0.
45
7±
0.
33
7
0.
48
6±
0.
26
6
0.
58
2±
0.
25
4
0.
62
5
0.
37
5
S2
-D
ef
oc
us
0.
33
7±
0.
35
1
0.
29
5±
0.
32
4
0.
31
3±
0.
30
7
0.
12
5
0.
87
5
S3
0.
11
6±
0.
06
0
0.
12
5±
0.
04
3
0.
13
2±
0.
02
7
0.
87
5
0.
62
5
S4
0.
06
6±
0.
02
1
0.
05
5±
0.
02
6
0.
05
7±
0.
02
7
0.
12
5
0.
12
5
S5
0.
02
2±
0.
00
8
0.
02
2±
0.
00
4
0.
02
6±
0.
00
3
0.
87
5
0.
62
5
S6
0.
01
4±
0.
00
3
0.
01
6±
0.
00
6
0.
01
4±
0.
00
6
0.
37
5
0.
62
5
To
ta
l H
O
0.
13
9±
0.
05
8
0.
14
1±
0.
04
9
0.
14
8±
0.
03
7
0.
87
5
0.
62
5
To
ta
l R
M
S
0.
49
2±
0.
31
5
0.
51
6±
0.
24
8
0.
60
4±
0.
24
7
0.
62
5
0.
37
5
Sp
h
−
0.
9±
0.
6D
−
1.
0±
0.
5D
−
1.
2±
0.
5D
0.
62
5
0.
25
0
cy
l
0.
8±
0.
8D
0.
7±
0.
8D
0.
8±
0.
7D
0.
12
5
0.
87
5
Sp
hE
q
−
0.
5±
0.
2D
−
0.
6±
0.
2D
−
0.
8±
0.
2D
0.
25
0
0.
12
5
N
o 
sig
ni
fic
an
t d
iff
er
en
ce
 in
 a
ll 
in
de
xe
s
*
Pa
ire
d 
W
ilc
ox
on
 S
ig
ne
d-
Ra
nk
 te
st 
on
 lo
ga
rit
hm
 o
f e
ac
h 
va
lu
e
Retina. Author manuscript; available in PMC 2013 July 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Bessho et al. Page 16
Table 7
Comparison of two controls of phakic (Control 1) and pseudophakic (Control 2) at 3mm scan
Phakic Pseudophakic %Difference of mean* P†
Sph 0.1±2.7 0.6±0.8 −83.6% 0.350
Cyl −1.3±0.8 −1±0.7 30.9% 0.149
Spherical Equivalent −0.6±2.7 0.1±0.9 −896.3% 0.229
S2 0.854±0.503 0.384±0.204 122.5% <0.001
S2-Defocus 0.291±0.172 0.251±0.175 15.9% 0.205
S3 0.094±0.053 0.118±0.066 −20.1% 0.068
S4 0.047±0.033 0.071±0.050 −33.9% 0.023
S5 0.016±0.012 0.026±0.016 −38.8% 0.003
S6 0.013±0.012 0.020±0.013 −38.0% 0.001
*%(Phakic-Pseudophakic)/Pseudophakic
†ANOVA
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